Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a ... this approval strengthens JNJ's psychiatric drug portfolio. However, Spravato remains ...

Emergent BioSolutions operates as a life sciences company that offers a Narcan Nasal Spray for opioid overdose ... of 2.23 for the Specialty & Generic Drug Manufacturing industry.

Drug overdoses and overdose deaths appear to ... must continue full force,” Cloud said in an email. Narcan nasal spray can save someone who is overdosing on an opioid such as oxycodone, heroin ...

Calculating a bolus dose is where insulin administration can ... a glucagon emergency kit on hand at all times. It’s a nasal spray or injection that treats severe hypoglycemia.

Data: San Diego County Medical Examiner's Office; Chart: Axios Visuals The big picture ... availability and affordability of naloxone, a nasal spray medication that reverses opioid overdoses ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...